On Wednesday I looked at three ASX shares that brokers have given buy ratings to this week.
Unfortunately, not all shares are in favour with them right now. Three that have just been given sell ratings are listed below.
Here's why these brokers are bearish on them:
Ansell Limited (ASX: ANN)
According to a note out of Macquarie, its analysts have retained their underperform rating but lifted the price target on this health and safety products company's shares to $30.40. Although the broker believes Ansell is well-positioned to benefit from increasing demand for personal protective equipment, it has concerns over capacity constraints. It doesn't believe the market is factoring this into its current valuation and thus believes its shares are overvalued. The Ansell share price is trading at $34.47 this afternoon.
Blackmores Limited (ASX: BKL)
A note out of Credit Suisse reveals that its analysts have retained their underperform rating but lifted their price target on this health supplements company's shares to $65.00. The broker appears to support the company's decision to strengthen its balance sheet. It also notes that Blackmores has reaffirmed its profit guidance for FY 2020. However, this isn't enough for a change in rating. The broker retains its underperform rating on valuation grounds. The Blackmores share price is up 1.5% to $80.10 on Thursday.
Sonic Healthcare Limited (ASX: SHL)
Analysts at UBS have retained their sell rating but lifted their price target on this healthcare company's shares to $25.10. The broker has been analysing pandemic testing data and believes that testing rates have already peaked in Australia. It also notes that testing rates have flattened in the UK and growth expected to slow in the United States. This could mean Sonic doesn't benefit as greatly as the market was expecting from testing activities. The Sonic share price is trading at $29.15 this afternoon
